Life Science Company
Sanofi SA has acquired 23 companies, including 3 in the last 5 years. A total of 7 acquisitions came from private equity firms. It has also divested 12 assets.
Sanofi SA’s largest acquisition to date was in 2011, when it acquired Genzyme for $20.1B. It’s largest disclosed sale occurred in 2018, when it sold Zentiva Group a.s. to Advent International for $2.2B. Sanofi SA has acquired in 8 different US states, and 9 countries. The Company’s most targeted sectors include life science (58%) and medical products (20%).
Join Mergr and gain access to Sanofi SA’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
M&A Summary
-
M&A Total Activity33
- M&A Buy Activity21
- M&A Sell Activity12
- Total Sectors Invested 5
- Total Countries Invested 9
- M&A Buy/Sell Connections 22
- M&A Advisors 6
Unlimited Searches
